Before the end date was announced, Pfizer and Moderna said they were considering selling their COVID-19 shots for at least $100 each. Blowback ensued, and Sen. Bernie Sanders called it “unacceptable corporate greed.” Moderna CEO Stéphane Bancel agreed to testify before Congress on March 22 about the vaccine’s proposed price, according to a news release from Mr. Sanders.
In a Feb. 15 news release, Moderna said it “remains committed to ensuring that people in the United States will have access to our COVID-19 vaccines regardless of ability to pay.”
“Moderna’s COVID-19 vaccines will continue to be available at no cost for insured people whether they receive them at their doctors’ offices or local pharmacies,” the drugmaker said. “For uninsured or underinsured people, Moderna’s patient assistance program (available after the PHE expires) will provide COVID-19 vaccines at no cost. Everyone in the United States will have access to Moderna’s COVID-19 vaccine regardless of their ability to pay.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
